These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16898963)

  • 1. The immature reticulocyte fraction: a negative predictor of the harvesting of CD34 cells for autologous peripheral blood stem cell transplantation.
    Dunlop LC; Cohen J; Harvey M; Gallo J; Motum P; Rosenfeld D
    Clin Lab Haematol; 2006 Aug; 28(4):245-7. PubMed ID: 16898963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic progenitor cell count, but not immature platelet fraction value, predicts successful harvest of autologous peripheral blood stem cells.
    Mitani N; Yujiri T; Tanaka Y; Tanaka M; Fujii Y; Hinoda Y; Tanizawa Y
    J Clin Apher; 2011; 26(3):105-10. PubMed ID: 21647950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the haematopoietic progenitor cell parameter in optimizing timing of peripheral blood stem cell harvest.
    Padmanabhan A; Reich-Slotky R; Jhang JS; Dael S; Crowder T; Colovai AI; Schwartz J
    Vox Sang; 2009 Aug; 97(2):153-9. PubMed ID: 19392781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The number of CD34(+) cells in peripheral blood as a predictor of the CD34(+) yield in patients going to autologous stem cell transplantation.
    Basquiera AL; Abichain P; Damonte JC; Ricchi B; Sturich AG; Palazzo ED; García JJ
    J Clin Apher; 2006 Jul; 21(2):92-5. PubMed ID: 16106446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.
    Torres A; Sánchez J; Lakomsky D; Serrano J; Alvarez MA; Martín C; Valls C; Nevado L; Rodriguez A; Casaño J; Martínez F; Gómez P
    Haematologica; 2001 Jan; 86(1):24-9. PubMed ID: 11146566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reticulocyte maturation parameters are reliable early predictors of hematopoietic engraftment after allogeneic stem cell transplantation.
    Molina JR; Sanchez-Garcia J; Torres A; Alvarez MA; Serrano J; Casaño J; Gomez P; Martinez F; Rodriguez A; Martin C
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):172-82. PubMed ID: 17241923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma.
    Schroeder H; Kamperis K; Grunnet N; Hokland P
    Pediatr Blood Cancer; 2006 Jun; 46(7):786-92. PubMed ID: 16333829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
    Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
    Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?
    Gidron A; Verma A; Doyle M; Boggio L; Evens A; Gordon L; Singhal S; Tallman M; Williams S; Winter J; Mehta J
    Bone Marrow Transplant; 2005 Feb; 35(3):243-6. PubMed ID: 15580281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of peripheral blood progenitor cell harvest based on peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE9000.
    Suh C; Kim S; Kim SH; Kim EK; Lee JL; Park KU; Park JS; Lee J; Kim MW; Chi HS; Park CJ; Kim SW
    Transfusion; 2004 Dec; 44(12):1762-8. PubMed ID: 15584992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the optimal timing of peripheral blood stem cell harvesting following priming with cyclophosphamide and G-CSF.
    Hill QA; Buxton D; Pearce R; Gesinde MO; Smith GM; Cook G
    Bone Marrow Transplant; 2007 Nov; 40(10):925-30. PubMed ID: 17846599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.
    Goterris R; Hernández-Boluda JC; Teruel A; Gómez C; Lis MJ; Terol MJ; Tormo M; Solano C; Arbona C
    Bone Marrow Transplant; 2005 Nov; 36(10):847-53. PubMed ID: 16113660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
    Statkute L; Verda L; Oyama Y; Traynor A; Villa M; Shook T; Clifton R; Jovanovic B; Satkus J; Loh Y; Quigley K; Yaung K; Gonda E; Krosnjar N; Spahovic D; Burt RK
    Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients.
    Grazziutti ML; Dong L; Miceli MH; Cottler-Fox M; Krishna SG; Fassas A; van Rhee F; Barlogie BM; Anaissie EJ
    Bone Marrow Transplant; 2006 Feb; 37(4):403-9. PubMed ID: 16400338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
    Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
    Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.